Ziad Zaky is a Nephrology physician affiliated with Cleveland Clinic. OpenAlex indexes 36 publications with 308 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9500 Euclid Ave
Desk Q7
Cleveland, OH 441950001
Telephone
216-445-0034Registry record last updated 25 Jul 2014.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- VERTEX PHARMACEUTICALS INCORPORATEDProgram year20253 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
34.1%Beta blocker11.7%Carvedilol64%Metoprolol Tartrate22%Metoprolol Succinate15%Part D<11 patientsStatin7.1%Atorvastatin Calcium76%Rosuvastatin Calcium24%Part D<11 patients+ 6 more classes in this area
Anti-infectives
30.5%Short-acting sulfonamides26.4%Sulfamethoxazole-Trimethoprim100%Part D≥88 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3.4%Valganciclovir Hcl100%Part D≥21 patients+ 1 more class in this area
Metabolism & gastrointestinal
26%Corticosteroid20.4%Prednisone100%Part D≥91 patientsProton pump inhibitor3.9%Pantoprazole Sodium59%Omeprazole41%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study
American Journal of Transplantation
2025 - Defining Relationships Among Tests for Kidney Transplant Antibody-Mediated Rejection
Kidney International Reports
2025 - Improving the histologic detection of donor-specific antibody-negative antibody-mediated rejection in kidney transplants
American Journal of Transplantation
2025 - Diagnostic Performance of Gene Expression and dd-cfDNA in Multiorgan Transplant Recipients
Transplantation Direct
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Steven Nissen, MD
Cleveland Clinic
Samir Kapadia, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Serpil Erzurum, MD
Cleveland Clinic
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”